Article

Using Machine-Learning Techniques to Identify Responders vs. Non-responders in Randomized Clinical Trials.

2020-11-23

Abstract excerpt

Despite the expectation of heterogeneity in therapy outcomes, especially for complex diseases like cancer, analyzing differential response to experimental therapies in a randomized clinical trial (RCT) setting is typically done by dividing patients into responders and non-responders, usually based on a single endpoint. Given the existence of biological and patho-physiological differences among metastatic colorecta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e0ca5135-89e2-5227-9270-e81c70340d3e
DOI: 10.1101/2020.11.21.20232041

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Using Machine-Learning Techniques to Identify Responders vs. Non-responders in Randomized Clinical Trials.DOI 10.1101/2020.11.21.20232041Read

Joint Prediction of Adjuvant Therapy Response and Time-to-Response for Cancer Patients Using the Personalized-DrugRank MethodSemantic proximity Read

Geometry based gene expression signatures detect cancer treatment responders in clinical trialsSemantic proximity Read

Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trials.Semantic proximity Read

Subpopulation-specific confidence designation for more informative biomedical classification.Semantic proximity Read

Phenotyping to predict 12-month health outcomes of older general medicine patientsSemantic proximity Read

Machine learning enabled subgroup analysis with real-world data to inform better clinical trial designSemantic proximity Read

An unsupervised machine learning method for discovering patient clusters based on genetic signatures.Semantic proximity Read

A machine learning method for subgroup analysis of randomized controlled trialsSemantic proximity Read

Use of Machine Learning to Derive Discrete Clinical Phenotypes and Assess Treatment-Effect Heterogeneity in the Steroids in Cardiac Surgery Trial Dataset.Semantic proximity Read

Qluster: An Easy-to-Implement Generic Workflow for Robust Clustering of Health DataSemantic proximity Read

Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker dataSemantic proximity Read

RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials.Semantic proximity Read